tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AEON Stock Latest News

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
Press ReleasesAEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
1M ago
AEON
Aeon Biopharma files $200M mixed securities shelf
PremiumThe Fly
Aeon Biopharma files $200M mixed securities shelf
1M ago
AEON
Aeon Biopharma price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
Aeon Biopharma price target lowered to $5 from $6 at H.C. Wainwright
1M ago
AEON
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
AEON
AEON Biopharma Releases New Corporate Presentation
PremiumCompany Announcements
AEON Biopharma Releases New Corporate Presentation
1M ago
8K
AEON
3 Penny Stocks to Watch Now, 7/18/24
PremiumMarket News3 Penny Stocks to Watch Now, 7/18/24
2M ago
AEON
NAAS
Aeon announces reprioritization to pursue biosimilar pathway for ABP-450
Premium
The Fly
Aeon announces reprioritization to pursue biosimilar pathway for ABP-450
2M ago
AEON
Aeon Biopharma discontinues Phase 2 study of ABP-450 in chronic migraine
Premium
The Fly
Aeon Biopharma discontinues Phase 2 study of ABP-450 in chronic migraine
4M ago
AEON
Aeon announces strategic resource reprioritization, cuts workforce by 55%
PremiumThe Fly
Aeon announces strategic resource reprioritization, cuts workforce by 55%
4M ago
AEON
AEON Biopharma Halts Migraine Study and Evaluates Strategy
PremiumCompany Announcements
AEON Biopharma Halts Migraine Study and Evaluates Strategy
4M ago
8K
AEON
Aeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
PremiumThe Fly
Aeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
4M ago
AEON
Aeon Biopharma provides update on development pipeline
PremiumThe Fly
Aeon Biopharma provides update on development pipeline
4M ago
AEON
Aeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
PremiumThe FlyAeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
5M ago
AEON
AEON Biopharma Phase 2 Migraine Treatment Trial Results
Premium
Company Announcements
AEON Biopharma Phase 2 Migraine Treatment Trial Results
5M ago
8K
AEON
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
Premium
Press Releases
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
5M ago
AEON
AEON Biopharma Bolsters Finance and Board with Daewoong Deal
PremiumCompany Announcements
AEON Biopharma Bolsters Finance and Board with Daewoong Deal
5M ago
8K
AEON
AEON Biopharma Announces Warrant Exercise Deadline and Terms
PremiumCompany Announcements
AEON Biopharma Announces Warrant Exercise Deadline and Terms
5M ago
8K
AEON
CORRECTION — AEON Biopharma Announces Redemption of Public Warrants
PremiumPress Releases
CORRECTION — AEON Biopharma Announces Redemption of Public Warrants
6M ago
AEON
AEON Biopharma Announces Redemption of Public Warrants
PremiumPress Releases
AEON Biopharma Announces Redemption of Public Warrants
6M ago
AEON
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesAEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
6M ago
AEON
AEON Biopharma Secures Strategic Financing for Clinical Development
Premium
Company Announcements
AEON Biopharma Secures Strategic Financing for Clinical Development
6M ago
8K
AEON
Aeon: EOP2 meeting with FDA productive, defined primary endpoint for Phase 3
Premium
The Fly
Aeon: EOP2 meeting with FDA productive, defined primary endpoint for Phase 3
6M ago
AEON

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >